For the upcoming Budget 2022, the Galen Centre for Health and Social Policy calls upon the government to strengthen its commitment and resolve towards addressing non-communicable diseases (NCDs) afflicting millions of Malaysians, which is expected to have significantly worsened since the onset of the Covid-19 pandemic.
The Galen Centre has five recommendations for the government’s consideration.
Before the emergence of Covid-19, Malaysia was already in the firm grip of a national health crisis, which grew larger, required more medical treatment, and claimed more lives each year. Cancer, diabetes, cardiovascular diseases and hypertension combined have already inflicted serious damage over the past decade on individuals, livelihoods and the economy.
For example, Malaysia has one of the worst five-year survival rates for breast cancer in Asia. 70 per cent of previous health budgets were forced to deal with the consequences of underinvestment in NCD prevention and control. We cannot afford to kick the can down the road on NCDs.
Here are five recommendations for Budget 2022:
1. A Larger Allocation For Health
The 2022 health budget should be between RM 35 to 40 billion. If we are to deal with existing health issues, ageing equipment, retaining skilled personnel, preparing and ensuring resilience to future pandemics such as Covid-19, much of Malaysia’s health infrastructure, including its people, needs additional investments and modernising. This is definitely not the time to under-invest in health.
2. Invest In Health Promotion, Health Literacy, NCD Treatment And Care
New funding should be channelled towards preventing and treating cancer, diabetes, and cardiovascular diseases. The incidences of various NCDs have and are expected to worsen and increase as a result of the Covid-19 crisis. We need to invest in improving health literacy, and ensure access and availability of effective treatment and care for those who need it.
3. Establish Sustainable Cancer Fund
A cancer fund should be established, with RM50 million in seed funding. It could be a form of public-private-patient partnership (3P) where the government, private sector and patient co-pay for treatment to increase the availability and quality of existing cancer therapies, particularly those which treat advanced cancers.
As a pilot programme, the government should earmark an initial five per cent from the revenue collected from alcohol and tobacco taxes (estimated totalling RM5.9 billion annually) for health promotion and treatment, focusing initially on diabetes and cancer.
This could support sustainability of a cancer fund and upscaling of innovative programmes or fund crucial lifesaving treatment.
4. Invest In Improving Health Care Infrastructure In Sabah And Sarawak
The Covid-19 outbreak in East Malaysia highlighted the state of health care in Sarawak and Sabah, which continues to need urgent attention and investment by the federal government.
Many long-standing critical issues such as maternal health service coverage and even primary care remain woefully inadequate.
People are clearly being left behind. In this budget, the government should identify a clear and separate funded plan for health care in these states.
It should grant a limited amount of autonomy for Sabah and Sarawak to manage its own health needs, including the building of infrastructure and recruitment of skilled personnel.
5. Raise Tobacco Taxes And Impose Taxes On Vape
Excise duties on tobacco products, especially cigarettes, have been frozen since 2015. It is time for cigarette taxes to be raised by 61.8 per cent from the existing retail price, to RM24.90 per pack.
Studies show that this increase in duties could potentially contribute RM3.36 billion in tax revenue, a 30 per cent increase above what was collected in 2019.
Since the government is adamant to regulate and not ban vape and e-cigarettes, it should impose a similar tax framework for such products similar to that of alcohol and tobacco products. The excise duties should cover nicotine and non-nicotine e-liquids and juices.
About 3.9 million people are living with diabetes, by 2030 more than 66,000 Malaysians are expected to be newly diagnosed with cancer each year, and a third of the population are currently suffering from hypertension.
The chronic nature of NCDs means patients are sick and suffer longer and require more medical care. The resulting economic costs are high and escalating.
According to the Ministry of Health (MOH) and the World Health Organization (WHO), in 2020, cardiovascular diseases, diabetes and cancer cost productivity losses of nearly RM9 billion annually for the Malaysian economy.
Azrul Mohd Khalib is CEO of the Galen Centre for Health and Social Policy.
- This is the personal opinion of the writer or publication and does not necessarily represent the views of CodeBlue.